Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled-Dose Study Using Cannabinoid Combinations in a Rapidly Dissolvable Sublingual Tablet for the Treatment of Dysmenorrhea and Associated Pain Symptoms

NCT04091789 is registered in ClinicalTrials.gov with Pure Green as lead sponsor.

NCT NCT04091789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04091789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled-Dose Study Using Cannabinoid Combinations in a Rapidly Dissolvable Sublingual Tablet for the Treatment of Dysmenorrhea and Associated Pain Symptoms
Lead sponsor
Pure Green
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2019
Completion date
May 31, 2020
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dysmenorrhea, fatigue, headache, migraine, mood disturbance, nausea